PT Hetzer Medical Indonesia Tbk (IDX:MEDS)
Indonesia · Delayed Price · Currency is IDR 59.00
+2.00 (3.51%)
Apr 1, 2026, 4:10 PM WIB
IDX:MEDS Market Cap
IDX:MEDS has a market cap or net worth of 89.06 billion as of April 1, 2026. Its market cap has increased by 14.00% in one year.
Market Cap
89.06B
Enterprise Value
95.61B
Revenue
4.58B
Ranking
n/a
PE Ratio
n/a
Stock Price
59.00
Market Cap Chart
Since August 10, 2022, IDX:MEDS's market cap has decreased from 262.50B to 89.06B, a decrease of -66.07%. That is a compound annual growth rate of -25.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 89.06B | -19.72% |
| Dec 30, 2025 | 110.94B | 42.00% |
| Dec 30, 2024 | 78.13B | -26.47% |
| Dec 29, 2023 | 106.25B | -49.25% |
| Dec 30, 2022 | 209.38B | -20.24% |
| Aug 10, 2022 | 262.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 180.31T |
| PT Kalbe Farma Tbk. | 42.60T |
| PT Siloam International Hospitals Tbk | 35.85T |
| PT Mitra Keluarga Karyasehat Tbk | 29.07T |
| PT Diagnos Laboratorium Utama Tbk | 372.50B |
| PT Ikapharmindo Putramas Tbk | 367.26B |
| PT Millennium Pharmacon International Tbk | 242.06B |
| PT Royal Prima Tbk | 233.10B |